We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+18.87%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$137M
AUM Growth
+$16.5M
(+14%)
Cap. Flow
+$772K
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
|
+$3.12M |
| 2 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$3.04M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.88M |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$2.01M |
| 5 |
Sutro Biopharma
STRO
|
+$611K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TECD
Tech Data Corp
TECD
|
+$7.91M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$4.15M |
| 3 |
LOGM
LogMein, Inc.
LOGM
|
+$2.89M |
| 4 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
+$548K |
| 5 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
+$505K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.76% |
| 2 | Healthcare | 21.07% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Communication Services | 3.33% |
Similar funds
SIAG
WI
MS
BHBT
WTFG
RC
VIA
A6
HighVista Strategies's Q3 2020 Portfolio in Review
As of Q3 2020, HighVista Strategies held 147 positions worth $137M, up 14% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
HighVista Strategies's Q3 2020 filing shows 47 new, 29 increased, 15 reduced and 34 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M. The largest sale was Tech Data Corp, an estimated $7.91M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.
- HighVista Strategies's largest Q3 2020 buy was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M.
- HighVista Strategies added most to Xenon Pharmaceuticals in Q3 2020, an estimated $274K increase.
- HighVista Strategies's biggest Q3 2020 reduction was Kadmon Holdings, Inc., cutting an estimated $256K.
- HighVista Strategies fully exited Tech Data Corp in Q3 2020, selling an estimated $7.91M.
- HighVista Strategies's ten largest holdings make up 69% of its $137M portfolio in Q3 2020.
- HighVista Strategies opened 47 new positions and closed 34 in Q3 2020.
- HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $137M.
Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.